Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models.
Detection of Anti-Aquaporin-4 Antibodies in a Patient With Glioma: A Case Report.
Statin-Associated Severe Rhabdomyolysis With Mixed Neuromuscular Involvement Mimicking Guillain‑Barré Syndrome: A Case Report.
No association of complex regional pain syndrome and other neurological disorders with human papillomavirus vaccination in a large-scale real-world database.
Early Anti-CD20 and CNS Penetrant BTK Inhibition to Enhance OPC-Driven Remyelination in Multiple Sclerosis.
Evolving MS criteria and the interpretation of research.
Human Autoantibodies Against MOG Isoforms: α3 Antibodies Suggest Relapsing Disease Course in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Intracellular complement factor H protects neurons during CNS inflammation.
Treg-derived IFN-γ supports the differentiation of Th1-Treg in tumor immunity and autoimmunity.
Establishing demographic-based normative values for neurofilament light chain and glial fibrillary acidic protein in serum and plasma samples.
Molecular Mechanisms of Cell Death in Multiple Sclerosis: Emerging Targets for Therapeutic Intervention.
Phosphodiesterase 8 (PDE8), a novel target for neurodegenerative diseases.
Extensive Osmotic Demyelination Syndrome With a Concomitant Cytotoxic Lesion of the Corpus Callosum in Hyperemesis Gravidarum: A Case Report.
Botulinum toxin treatment for multiple sclerosis and post-stroke spasticity in clinical practice: differences in injection doses and patterns.
The Eye and the Brain: Photonic Devices in Neuro-Ophthalmology.
Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications.
Cyclodextrin-Based Strategies for Brain Drug Delivery: Mechanistic Insights into Blood-Brain Barrier Transport and Therapeutic Applications.
Lysosomal multi-omics reveals altered sphingolipid catabolism associated with lysosomal dysfunction in the aging brain.
Autophagy-lysosome networks in oligodendrocytes: a dynamic framework for myelin integrity.
Broadening the understanding of fatigue in multiple sclerosis: a qualitative study protocol of the EMA-FAMS project.
Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives.
Axonal dying back of upper motor neurons in human ALS.
Regulation of microglial activation by progranulin through the NF-κB pathway in subarachnoid hemorrhage and its effect on white matter injury.
Accelerated Brain Aging in Multiple Sclerosis: Microstructural and Metabolic Correlates of the Brain Age Gap.
Real-World Data for Safety Studies: Challenges and Opportunities From the Italian Multiple Sclerosis and Related Disorders Register.
Pages
« first
‹ previous
…
817
818
819
820
821
822
823
824
825
…
next ›
last »